免疫抑制
肝细胞癌
串扰
调解人
癌症研究
仿形(计算机编程)
生物
计算生物学
医学
免疫学
细胞生物学
计算机科学
操作系统
光学
物理
作者
Zhiyong Liu,Xiahui Lin,Hongying Guo,Xuan Shi,Danying Zhang,Jialei Sun,Guangcong Zhang,Ru-Chen Xu,Fu Wang,Xiang‐Nan Yu,Dou Wang,Shuqiang Weng,Xizhong Shen,Taotao Liu,Ling Dong,Ji‐Min Zhu
摘要
Dysregulation of the aldehyde dehydrogenase (ALDH) family has been implicated in various pathological conditions, including cancer.However, a systematic evaluation of ALDH alterations and their therapeutic relevance in hepatocellular carcinoma (HCC) remains lacking.Herein, we found that 15 of 19 ALDHs were transcriptionally dysregulated in HCC tissues compared to normal liver tissues.A four gene signature, including ALDH2, ALDH5A1, ALDH6A1, and ALDH8A1, robustly predicted prognosis and defined a high-risk subgroup exhibiting immunosuppressive features like regulatory T cell (Tregs) infiltration.Single-cell profiling revealed selective overexpression of tumor necrosis factor receptor superfamily member 18 (TNFRSF18) on Tregs, upregulated in high-risk HCC patients.We identified ALDH2 as a tumor suppressor in HCC, with three novel phosphorylation sites mediated by protein kinase C zeta that enhanced enzymatic activity.Mechanistically, ALDH2 suppressed Tregs differentiation by inhibiting β-catenin/TGF-β1 signaling in HCC.Collectively, our integrated multi-omics analysis defines an ALDH-Tregs-TNFRSF18 axis that contributes to HCC pathogenesis and represents potential therapeutic targets for this aggressive malignancy.
科研通智能强力驱动
Strongly Powered by AbleSci AI